NCT06173596View on ClinicalTrials.gov

A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

May 16, 2024

Conditions
Healthy
Interventions
DRUG

ALXN2080

Participants will receive ALXN2080 orally.

DRUG

Itraconazole

Participants will receive Itraconazole orally.

DRUG

Fluconazole (AxMP)

Participants will receive Fluconazole orally.

DRUG

Carbamazepine (AxMP)

Participants will receive Carbamazepine orally.

Trial Locations (1)

NG11 6JS

Research Site, Ruddington

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY